Seok Joo Lee – CEO, ISU Abxis, South Korea
ISU Abxis, a subsidiary of the ISU conglomerate, is a biotech company with a focus on orphan drugs and rare disease. CEO Seok Joo Lee explains the rationale behind his…
Address: 5F, DaeHan Bldg 201-6, Guui-Dong, Kwangjin-Gu Seoul,Republic of Korea
Tel: +82 2 456 3043
KRPIA represents Republic of Korean Research-based Pharmaceutical Industry Association. KRPIA is the association of research-based companies which deliver innovative new medicines to the market through incessant research endeavors. KRPIA was established in March 1999, consisting of 24 multinational research-based pharmaceutical companies operating in Republic of Korea. At present, KRPIA has 28 member companies which are taking the lead in the world’s pharmaceutical market. KRPIA believes ‘New Medicines, New Hope’ so it is devoted to providing new innovative drugs in Republic of Korea and disseminating pharmaceutical-related information. KRPIA members have the best possible conditions to research, develop, market and inform about their pharmaceuticals, thus ensuring broad and fast access for patients to the best medical treatment. The value of research based medicines for the Republic of Korean society is visible and recognized in a health system with the patient as priority. The Republic of Korean Research-based Pharmaceutical Industry Association is perceived as a responsible partner that makes a valuable contribution to society.Mision: Promote the development and prompt introduction of innovative new pharmaceuticals Enhance the ethical standards of the pharmaceutical industry Strengthen the pharmaceutical industry’s contribution to the advancement of public health Effectively disseminate pharmaceutical-related information and contribute to medical treatment for patients and public health promotion
ISU Abxis, a subsidiary of the ISU conglomerate, is a biotech company with a focus on orphan drugs and rare disease. CEO Seok Joo Lee explains the rationale behind his…
Looking at what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. DHR International’s Helen Park outlines what she…
Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee, general manager of Syneos Korea, provides…
SK Group, the second largest conglomerate in South Korea and renowned as a leader in energy, telecommunications, and the semiconductor business, entered drug development in 1993. In an exclusive interview,…
Bong Gil Nam, chairman and owner of Pharmbio Korea, offers his insights on his company’s importance in differentiating itself from the generic competitors in the market. Mr Nam also explains…
Bioneer, founded in 1992, lays claim to be Korea’s oldest biotechnology company. President, founder and CEO, Dr Han-Oh Park introduces the technological advances they have developed in molecular research tools,…
The Korea Drug Development Fund (KDDF) is a government-funded organization created to accelerate innovation activities in the Korean life sciences sector. In this interview, Samuel Muk explains how he integrated…
Dr Nam Han Cho, president of the International Diabetes Federation (IDF) and professor of Preventive Medicine at the Ajou University School of Medicine in South Korea is taking stock of his…
This week, the Korean Ministry of Food and Drug Safety announced that it would enhance drug safety management and make a new, streamlined review process for advanced healthcare goods. The…
The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries through increased international collaboration. However, some pharma insiders are…
Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean patients by utilising legislation regarding orphan drugs to fast track the market entry…
It was less than a decade ago (2011) that Samsung Biologics was a new kid on the block amongst Korea’s booming biotech conglomerates. Since then the company has snowballed, building…
See our Cookie Privacy Policy Here
